Key player in national and regional Market Access, we ensure high quality, originality and neutrality in different contexts:
scientific
medical
regulatory
institutional
healthcare
Since 2008, we have adopted a working method strongly based on constructive dialectic to develop innovative thoughts and proposals, creating dialogue and consensus between Pharmaceutical and Biomedical Companies and opinion leaders from medical, healthcare, and institutional settings.
Support the scientific coordination and organizational platform of 16 scientific societies, with multidisciplinary initiatives and policy documents focused on cardiovascular risk research and prevention as a primary objective.